Al G. Dossetter


Al G. Dossetter gained his Ph.D. from Nottingham University and after postdoctoral research at Harvard University joined AstraZeneca. He has 13 years of experience in medicinal chemistry spread across oncology (hormonal and kinase inhibitors), inflammation (OA and RA, enzyme inhibitors, and GPCR targets), and diabetes (obesity, GPCR, and enzyme inhibitors). In 2012, he cofounded MedChemica

Al G. Dossetter2022-07-19T10:10:33+00:00

Ed J. Griffen


Ed J. Griffen obtained his Ph.D. from Imperial College, London, and undertook postdoctoral research at the University of Waterloo-Kitchener, Canada. He joined Zeneca Pharmaceuticals in medicinal chemistry working in the CNS, infection, oncology, and chemical biology areas. Taking a secondment into the computational chemistry group, he co-developed matched molecular pair tools to quantify medicinal chemistry

Ed J. Griffen2017-11-09T08:44:09+00:00

Andrew G. Leach


Andrew G. Leach obtained his Ph.D. from the University of Cambridge and undertook postdoctoral research at UCLA, supported by the Fulbright scheme. He returned to the UK to join AstraZeneca as a computational chemist and worked in oncology, diabetes, and obesity. In 2012, he became one of the cofounders of MedChemica Limited and also joined

Andrew G. Leach2017-11-09T06:55:09+00:00
Go to Top